The telomerase inhibitor imetelstat alone, and in combination with trastuzumab, decreases the cancer stem cell population and self-renewal of HER2+ breast cancer cells
Crossref DOI link: https://doi.org/10.1007/s10549-015-3270-1
Published Online: 2015-01-28
Published Print: 2015-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Koziel, Jillian E.
Herbert, Brittney-Shea
Text and Data Mining valid from 2015-01-28